The most valued company in the United States is not the firm you think it is. There's certainly something to be said for staying power.

Investors interested in profiting from Warren Buffett’s investment acumen should consider this alternative to Berkshire Hathaway. It's a back door strategy that allows investors to own the stock at a -17% discount.

This week's Trade of the Week comes from the pharmaceutical sector. This company is one of the world's leading providers of health care products. Its strong drug portfolio and diverse revenue stream could lead to big profits -- and even bigger yields for investors.

A game-changing product is making a few companies -- and their shareholders -- a lot of money. A key acquisition points to the industry's standout.

Last October, when the markets seemed at their worst, Warren Buffett told us not to give up on U.S. stocks. But it was one investment in particular that stands out as perhaps his shrewdest move in decades. Learn about these little known income securities and how a major disconnect in the market can still net big yields and significant appreciation potential for investors.

Everyday investors will have a chance to own the market's most coveted investment -- Warren Buffett's Berkshire Hathaway -- for the first time. Here's how.

These little stocks are not only cheap, they also pay huge dividends.

Don't be fooled by the market's rebound. Investors can still buy companies at dirt-cheap prices. But don't wait long, because bottom-feeders aren’t going to miss out on the chance to scoop up these companies for pennies on the dollar.

Some said TV would kill movies. Some are sounding a similar note with digital content. But with major new technological advancements -- and growth abroad -- the movie business is booming, and smart investors aren't counting this cinema chain out.

The S&P’s triple-A credit rating typically means a lousy dividend, but plenty of highly rated companies offer rich revenue streams. The best one may surprise you.